Parsaclisib

CAS: 1426698-88-5

Ref. 3D-BHC69888

Produktinformation

• Name: Parsaclisib

Beschreibung

Parsaclisib is a secretase inhibitor that has been shown to be effective in treating multiple types of cancer, including lung, pancreatic, and colorectal cancers. It is also being investigated for use in the treatment of Alzheimer's disease and other autoimmune diseases. Parsaclisib inhibits the production of amyloid beta protein by reducing its production by inhibiting the enzyme β-secretase. This drug has been shown to increase glomerular filtration rate (GFR) in patients with chronic kidney disease. Parsaclisib is a promising drug for the treatment of infectious diseases such as HIV/AIDS because it suppresses viral replication without affecting normal cells.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 432.9 g/mol
• Formel: C₂₀H₂₂ClFN₆O₂
• Reinheit: Min. 95%